Eloxx Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q4 2022.
  • Eloxx Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $80M, a 11.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $80M +$8.39M +11.7% Dec 31, 2022 10-K 2023-03-31
Q4 2021 $71.6M +$19M +36.1% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $52.6M +$5.9M +12.6% Dec 31, 2020 10-K 2022-03-30
Q4 2019 $46.7M +$10.8M +30.1% Dec 31, 2019 10-K 2021-03-12
Q4 2018 $35.9M +$7.73M +27.5% Dec 31, 2018 10-K 2020-03-06
Q4 2017 $28.1M +$24.1M +600% Dec 31, 2017 10-K 2019-03-14
Q2 2017 $29.5M +$701K +2.44% Jun 30, 2017 10-K 2017-10-13
Q4 2016 $4.02M Dec 31, 2016 10-K 2018-03-16
Q2 2016 $28.8M -$2.59M -8.26% Jun 30, 2016 10-K 2017-10-13
Q2 2015 $31.4M +$4.26M +15.7% Jun 30, 2015 10-K 2016-10-13
Q2 2014 $27.1M +$5.27M +24.2% Jun 30, 2014 10-K 2016-10-13
Q2 2013 $21.8M +$1.88M +9.43% Jun 30, 2013 10-K 2014-09-29
Q2 2012 $19.9M +$2M +11.2% Jun 30, 2012 10-K 2013-09-11
Q2 2011 $17.9M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.